211 results on '"Mikhailidis, Dimitri P."'
Search Results
2. An evaluation of RVX-208 for the treatment of atherosclerosis
3. Statins can improve proteinuria and glomerular filtration rate loss in chronic kidney disease patients, further reducing cardiovascular risk. Fact or fiction?
4. Statin intolerance – an attempt at a unified definition. Position paper from an International Lipid Expert Panel
5. Strategies to overcome statin intolerance
6. Fibroblast growth factor 19-targeted therapies for the treatment of metabolic disease
7. Should we consider ezetimibe to reach even lower LDL-C targets?
8. How effective are the ESC/EAS and 2013 ACC/AHA guidelines in treating dyslipidemia? Lessons from a lipid clinic
9. Short-, mid-, and long-term benefits of peri-procedural high-intensity statin administration in patients undergoing percutaneous coronary intervention
10. Genetic, epidemiologic and clinical data strongly suggest that fasting or non-fasting triglycerides are independent cardiovascular risk factors
11. Risk of illness, hospitalization and death in a cohort of blood donors in Italy
12. The 2013 American College of Cardiology/American Heart Association guidelines for the treatment of dyslipidemia: mind the gaps!
13. Summarizing the FIELD study: lessons from a ‘negative' trial
14. Reaching hypertriglyceridemia goals
15. Are statins ‘IDEAL’ for non-alcoholic fatty liver disease?
16. Statins and nonalcoholic fatty liver disease: a bright future?
17. Clinical benefits of ezetimibe use: is absence of proof, proof of absence?
18. Stage of chronic kidney disease and severity of coronary heart disease manifestation
19. Therapeutic options for statin-intolerant patients
20. Managing the combination of non-alcoholic fatty liver disease and metabolic syndrome
21. Metformin and heart failure: never say never again
22. Relationships of osteoprotegerin with albuminuria and asymmetric dimethylarginine in essential hypertension: integrating vascular dysfunction
23. Glycated hemoglobin A1c(HbA1c) and diabetes: a new era?
24. The role of ezetimibe in LDL cholesterol goal attainment in very high risk patients
25. Current treatment for nonalcoholic fatty liver disease
26. What is the risk of hyperkalaemia in heart failure?
27. The effects of rosuvastatin alone or in combination with fenofibrate or omega 3 fatty acids on inflammation and oxidative stress in patients with mixed dyslipidemia
28. What should be the optimal levels of blood pressure: does the J-curve phenomenon really exist?
29. Comparative efficacy of the addition of ezetimibe to statin vs statin titration in patients with hypercholesterolaemia: systematic review and meta-analysis
30. Prevalence of low high-density lipoprotein cholesterol (HDL-C) as a marker of residual cardiovascular risk among acute coronary syndrome patients from Oman
31. Emerging options in the treatment of dyslipidemias: a bright future?
32. Cilostazol and atherogenic dyslipidemia: a clinically relevant effect?
33. Ezetimibe and low density lipoprotein subfractions: an ongoing debate
34. Effect of various treatments on leptin, adiponectin, ghrelin and neuropeptide Y in patients with type 2 diabetes mellitus
35. The DEFINE study: a bright future for CETP inhibitors?
36. Statins and dilated cardiomyopathy: do we have enough data?
37. Dapagliflozin: more than just another oral glucose-lowering agent?
38. Na+/H+exchanger-1: a link with atherogenesis?
39. Ezetimibe in diabetes: more than cholesterol lowering?
40. Statin-fibrate combination for mixed dyslipidaemia: a limited option?
41. Metformin and cancer: licence to heal?
42. Atorvastatin: safety and tolerability
43. Lipid-lowering agents and new onset diabetes mellitus
44. Impact of managing atherogenic dyslipidemia on cardiovascular outcome across different stages of diabetic nephropathy
45. Statin loading in patients undergoing percutaneous coronary intervention for acute coronary syndromes: a new pleiotropic effect?
46. Undertreatment of hypercholesterolemia
47. Vernakalant hydrochloride for the treatment of atrial fibrillation
48. Role and significance of statins in the treatment of hypertensive patients
49. Statins and venous thromboembolism: a novel effect of statins?
50. Nephroprotective and clinical potential of statins in dialyzed patients
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.